Although VEGF blockade exhibits promising anti-cancer therapeutic efficacy, by normalizing tumor vasculature, the optimal time and dosage of anti-VEGF treatments have been proposed to be the determinants for effective vessel normalization [2,117]. Here, VEGFA is linked to cancer.